|Institutional Source||Beutler Lab|
|Is this an essential gene?||Possibly non essential (E-score: 0.358)|
|Stock #||R4576 (G1)|
|Chromosomal Location||12798606-12833807 bp(+) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||T to C at 12833290 bp|
|Amino Acid Change||Isoleucine to Threonine at position 366 (I366T)|
|Ref Sequence||ENSEMBL: ENSMUSP00000025601 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000025601]|
|Predicted Effect||probably benign
AA Change: I366T
PolyPhen 2 Score 0.170 (Sensitivity: 0.92; Specificity: 0.87)
AA Change: I366T
|Meta Mutation Damage Score||0.1|
|Coding Region Coverage||
|Validation Efficiency||98% (84/86)|
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The product encoded by this gene is preferentially expressed in hematopoietic cells and belongs to the paxillin protein family. Similar to other members of this focal-adhesion-associated adaptor-protein family, it has four leucine-rich LD-motifs in the N-terminus and four LIM domains in the C-terminus. It may function in cell type-specific signaling by associating with PYK2, a member of focal adhesion kinase family. As a substrate for a tyrosine kinase in lymphoid cells, this protein may also function in, and be regulated by, tyrosine kinase activity. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Jan 2009]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Lpxn||
(F):5'- AACTGGATGGCCGTCCTTTC -3'
(R):5'- TCAGAGGCTCTTGATAGCATG -3'
(F):5'- GATGGCCGTCCTTTCTGTGAAC -3'
(R):5'- GTAACATCTACAAAGGCCCGTTTG -3'